1. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
   Xingchun Gao et al, 2017, Front. Immunol. CrossRef
2. Resolvins suppress tumor growth and enhance cancer therapy
   Megan L. Sulciner et al, 2017, J. Exp. Med. CrossRef
3. DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.
   Wenxing Qin et al, 2018, J Cell Mol Med CrossRef
4. Checkpoints and beyond – Immunotherapy in colorectal cancer
   Tobias Gutting et al, 2018, Seminars in Cancer Biology CrossRef
5. TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis 
   Aizhang Xu et al, 2018, Cell Mol Immunol CrossRef
6. Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
   Jaimie Chang et al, 2019, The FASEB Journal CrossRef
7. Cytokine-induced killer cells co-cultured with non-cell derived targeting peptide-loaded dendritic cells induce a specific antitumor response
   Cuijuan Liu et al, 2019, Cancer Biology & Therapy CrossRef
8. Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer
   Chunyan Liu et al, 2019, Journal of Immunology Research CrossRef
9. Evolution of Thermal Dosimetry for Application of Hyperthermia to Treat Cancer
   Mark W. Dewhirst et al, 2015 CrossRef
10. From Local to Systemic Treatment: Leveraging Antitumor Immunity Following Irreversible Electroporation
    Anita G. M. Stam et al, 2018 CrossRef
11. Effect of cytokine‑induced killer cells combined with dendritic cells on the survival rate and expression of 14‑3‑3ζ and p‑Bad proteins in Lewis lung cancer cell lines
    Yang Hou et al, 2018, Oncol Lett CrossRef
12. Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol
    Bart Geboers et al, 2021, Cancers CrossRef
13. Current status and future perspective of immune checkpoint inhibitors in colorectal cancer
    Cong Zhou et al, 2021, Cancer Letters CrossRef
14. The complex roles of efferocytosis in cancer development, metastasis, and treatment
    Amir Tajbakhsh et al, 2021, Biomedicine & Pharmacotherapy CrossRef
15. Combination therapy of irreversible electroporation and cytokine-induced killer cells for treating mice bearing panc02 pancreatic-cancer xenografts
    Baohua Wang et al, 2023, Biochemistry and Biophysics Reports CrossRef
16. Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials
    Yingge Lv et al, 2024 CrossRef
17. Radiofrequency ablation: mechanisms and clinical applications
    Jianhua Wu et al, 2024, MedComm CrossRef